Infiniplex
3 known investors
Infiniplex is a precision oncology company developing InfiniplexDX, a liquid biopsy platform that uses proprietary primer design and molecular-switch chemistry with software-based signal analysis to detect cancer mutations in blood and urine on standard PCR instruments. It targets five clinical indications (bladder cancer, myelodysplastic syndromes, pancreatic, colorectal, and non-small cell lung cancer) to support treatment decisions without tissue biopsies.
Founders & leadership
AS
Alon ShalevCEO
ZR
Zeev RussakCTO
EH
Efrat HerscovitchCFO
AE
Asa EitanCSO
Investors ยท 3
In the news
Frequently asked questions
- What does Infiniplex do?
- Infiniplex is a precision oncology company developing InfiniplexDX, a liquid biopsy platform that uses proprietary primer design and molecular-switch chemistry with software-based signal analysis to detect cancer mutations in blood and urine on standard PCR instruments. It targets five clinical indications (bladder cancer, myelodysplastic syndromes, pancreatic, colorectal, and non-small cell lung cancer) to support treatment decisions without tissue biopsies.
- Who are Infiniplex's investors?
- Infiniplex's investors include Bosch Ventures, Robert Bosch Venture Capital, Terra Venture Partners.